Reckitt Benckiser Aktie
67,56
EUR
+1,22
EUR
+1,84
%
59,10
GBP
+1,06
GBP
+1,83
%
Werbung
Reckitt Benckiser Aktie Analyse
05.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
02.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
28.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
28.03.24 | Reckitt Benckiser Buy | UBS AG | |
19.03.24 | Reckitt Benckiser Buy | UBS AG | |
18.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
18.03.24 | Reckitt Benckiser Buy | UBS AG | |
18.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
Werbung
|
|||
18.03.24 | Reckitt Benckiser Outperform | Bernstein Research | |
15.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
08.03.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
06.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
04.03.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
01.03.24 | Reckitt Benckiser Kaufen | DZ BANK | |
29.02.24 | Reckitt Benckiser Overweight | Barclays Capital | |
28.02.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
28.02.24 | Reckitt Benckiser Buy | UBS AG | |
28.02.24 | Reckitt Benckiser Outperform | Bernstein Research | |
28.02.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
28.02.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
28.02.24 | Reckitt Benckiser Overweight | Barclays Capital | |
23.02.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
12.02.24 | Reckitt Benckiser Outperform | Bernstein Research | |
02.02.24 | Reckitt Benckiser Buy | UBS AG | |
01.02.24 | Reckitt Benckiser Overweight | Barclays Capital | |
15.01.24 | Reckitt Benckiser Buy | UBS AG | |
10.01.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
28.12.23 | Reckitt Benckiser Outperform | Bernstein Research | |
19.12.23 | Reckitt Benckiser Overweight | Barclays Capital | |
18.12.23 | Reckitt Benckiser Buy | UBS AG | |
18.12.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
12.12.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
11.12.23 | Reckitt Benckiser Outperform | Bernstein Research | |
29.11.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
03.11.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
02.11.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
26.10.23 | Reckitt Benckiser Buy | UBS AG | |
25.10.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
25.10.23 | Reckitt Benckiser Buy | UBS AG | |
25.10.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
05.10.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
25.09.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
13.09.23 | Reckitt Benckiser Overweight | Barclays Capital | |
01.09.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
23.08.23 | Reckitt Benckiser Overweight | Barclays Capital | |
23.08.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
21.08.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
08.08.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
08.08.23 | Reckitt Benckiser Buy | UBS AG | |
27.07.23 | Reckitt Benckiser Overweight | Barclays Capital |
Werbung
Werbung